Vice President, Translational Medicine
Nektar Therapeutics is a biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and advanced polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. The Companys product pipeline is comprised of drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. Nektars research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. It creates its drug candidates by using its chemistry platform to modify the chemical structure of drugs using polymer conjugates. Nektars drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.
I am a highly motivated, flexible, and detail-oriented biopharmaceutical scientist with demonstrated scientific excellence in oncology, immuno-oncology, and autoimmunity drug and diagnostic development. Recognized for being a collaborative team builder and a key contributor on cross-functional global project teams with demonstrated analytical, communication, and decision-making abilities.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Christie Fanton at Nektar Therapeutics then you've come to the right place.
Wondering if it's christie@nektar.com, christie.fanton@nektar.com, fanton@nektar.com, or cfanton@nektar.com? We have the answers for you.